Figures index

From

Ameliorative Potential of Thiazolidinediones and Statins on Experimentally Induced Non-Alcoholic Steatohepatitis

Ahmed M Kabel, Hany M Borg

World Journal of Nutrition and Health. 2014, 2(4), 52-57 doi:10.12691/jnh-2-4-2
  • Figure 1. A (Serum ALT); B (Serum AST); C (Serum ALP); D (Serum TNF-alpha); E (Serum triglycerides) and F (Serum total cholesterol) in the studied groups
  • Figure 2. A (Fasting serum glucose); B (Fasting serum insulin); C (HOMA-IR); D (Hepatic triglycerides); E (Hepatic free fatty acids) and F (Hepatic malondialdehyde) in the studied groups
  • Figure 3. Section from liver of normal group showed normal liver cells with norml lobular architecture (H&E X 250)
  • Figure 4. Section from liver of NASH group showed extensive steatosis with marked inflammation (H&E X 250)
  • Figure 5. Section from liver of atorvastatin treated group showed minimal steatosis with no inflammation (H&E X 250)
  • Figure 6. Section from liver of pioglitazone treated group showed minimal steatosis with no inflammation (H&E X 250)
  • Figure 7. Section from liver of atorvastatin + pioglitazone treated group showed minimal steatosis with no inflammation and more or less normal lobular architecture (H&E X 250)